sr 33557 has been researched along with Malaria, Falciparum in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adovelande, J; Delèze, J; Schrével, J | 1 |
1 other study(ies) available for sr 33557 and Malaria, Falciparum
| Article | Year |
|---|---|
Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Calcium Channel Blockers; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Humans; Indolizines; Malaria, Falciparum; Phenethylamines; Plasmodium falciparum; Verapamil | 1998 |